HF
RLYB icon

HRT Financial’s Rallybio RLYB Stock Holding History

HRT Financial’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,673
Closed -$14K – 4586
2025
Q4 		$14K Sell
2,673
-1,355
-34% -$6.97K ﹤0.01% 3028
2025
Q3 		$16K Buy
4,028
+327
+9% +$1.37K ﹤0.01% 2725
2025
Q2 		$10K Buy
+3,701
New +$9.81K ﹤0.01% 2456
2024
Q3 		– Sell
-3,121
Closed -$33K – 3024
2024
Q2 		$33K Buy
+3,121
New +$42.3K ﹤0.01% 1884

Other funds holding RLYB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

HRT Financial's RLYB Position: Q1 2026 in Review

HRT Financial sold out of Rallybio (RLYB) in Q1 2026, closing a stake of 2,673 shares — an estimated $14K sold.

HRT Financial first reported a position in RLYB in Q2 2024 and held it in 4 quarters. The position peaked at $33K in Q2 2024. 38 funds tracked by Wall St. Rank hold RLYB as of Q1 2026.

  • HRT Financial reported no remaining Rallybio position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 2,673 Rallybio shares in Q1 2026, an estimated $14K.
  • HRT Financial first reported a position in Rallybio in Q2 2024 and held it in 4 quarters.
  • HRT Financial's Rallybio position peaked at $33K in Q2 2024.
  • 38 funds tracked by Wall St. Rank held Rallybio as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.